|15.70||-0.72 / -4.38%|
Data as of 4:00pm ET
|15.70||+0.0019 / +0.01%|
The 5 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 22.00, with a high estimate of 33.00 and a low estimate of 17.00. The median estimate represents a +40.13% increase from the last price of 15.70.
The current consensus among 5 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.